64 related articles for article (PubMed ID: 33235183)
41. Tumor suppressive role for kinases phosphorylating p53 in DNA damage-induced apoptosis.
Yogosawa S; Yoshida K
Cancer Sci; 2018 Nov; 109(11):3376-3382. PubMed ID: 30191640
[TBL] [Abstract][Full Text] [Related]
42. GeneMANIA update 2018.
Franz M; Rodriguez H; Lopes C; Zuberi K; Montojo J; Bader GD; Morris Q
Nucleic Acids Res; 2018 Jul; 46(W1):W60-W64. PubMed ID: 29912392
[TBL] [Abstract][Full Text] [Related]
43. LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
Vasaikar SV; Straub P; Wang J; Zhang B
Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207
[TBL] [Abstract][Full Text] [Related]
44. Nucleome Analysis Reveals Structure-Function Relationships for Colon Cancer.
Seaman L; Chen H; Brown M; Wangsa D; Patterson G; Camps J; Omenn GS; Ried T; Rajapakse I
Mol Cancer Res; 2017 Jul; 15(7):821-830. PubMed ID: 28258094
[TBL] [Abstract][Full Text] [Related]
45. Colorectal cancer statistics, 2017.
Siegel RL; Miller KD; Fedewa SA; Ahnen DJ; Meester RGS; Barzi A; Jemal A
CA Cancer J Clin; 2017 May; 67(3):177-193. PubMed ID: 28248415
[TBL] [Abstract][Full Text] [Related]
46. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
47. Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.
Ma J; Guan M; Bowden DW; Ng MCY; Hicks PJ; Lea JP; Ma L; Gao C; Palmer ND; Freedman BI
Clin J Am Soc Nephrol; 2016 Jun; 11(6):1034-1043. PubMed ID: 27197912
[TBL] [Abstract][Full Text] [Related]
48. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
Karimian A; Ahmadi Y; Yousefi B
DNA Repair (Amst); 2016 Jun; 42():63-71. PubMed ID: 27156098
[TBL] [Abstract][Full Text] [Related]
49. Association study between genome-wide significant variants of vitamin B12 metabolism and gastric cancer in a han Chinese population.
Zhao L; Wei Y; Song A; Li Y
IUBMB Life; 2016 Apr; 68(4):303-10. PubMed ID: 26959381
[TBL] [Abstract][Full Text] [Related]
50. A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.
Al-Tassan NA; Whiffin N; Hosking FJ; Palles C; Farrington SM; Dobbins SE; Harris R; Gorman M; Tenesa A; Meyer BF; Wakil SM; Kinnersley B; Campbell H; Martin L; Smith CG; Idziaszczyk S; Barclay E; Maughan TS; Kaplan R; Kerr R; Kerr D; Buchanan DD; Win AK; Hopper J; Jenkins M; Lindor NM; Newcomb PA; Gallinger S; Conti D; Schumacher F; Casey G; Dunlop MG; Tomlinson IP; Cheadle JP; Houlston RS
Sci Rep; 2015 May; 5():10442. PubMed ID: 25990418
[TBL] [Abstract][Full Text] [Related]
51. Genetic modifiers of folate, vitamin B-12, and homocysteine status in a cross-sectional study of the Canadian population.
Zinck JW; de Groh M; MacFarlane AJ
Am J Clin Nutr; 2015 Jun; 101(6):1295-304. PubMed ID: 25948668
[TBL] [Abstract][Full Text] [Related]
52. Vitamin D metabolic pathway genes and pancreatic cancer risk.
Arem H; Yu K; Xiong X; Moy K; Freedman ND; Mayne ST; Albanes D; Arslan AA; Austin M; Bamlet WR; Beane-Freeman L; Bracci P; Canzian F; Cotterchio M; Duell EJ; Gallinger S; Giles GG; Goggins M; Goodman PJ; Hartge P; Hassan M; Helzlsouer K; Henderson B; Holly EA; Hoover R; Jacobs EJ; Kamineni A; Klein A; Klein E; Kolonel LN; Li D; Malats N; Männistö S; McCullough ML; Olson SH; Orlow I; Peters U; Petersen GM; Porta M; Severi G; Shu XO; Visvanathan K; White E; Yu H; Zeleniuch-Jacquotte A; Zheng W; Tobias GS; Maeder D; Brotzman M; Risch H; Sampson JN; Stolzenberg-Solomon RZ
PLoS One; 2015; 10(3):e0117574. PubMed ID: 25799011
[TBL] [Abstract][Full Text] [Related]
53. Pathway and network analysis in proteomics.
Wu X; Hasan MA; Chen JY
J Theor Biol; 2014 Dec; 362():44-52. PubMed ID: 24911777
[TBL] [Abstract][Full Text] [Related]
54. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Gao J; Aksoy BA; Dogrusoz U; Dresdner G; Gross B; Sumer SO; Sun Y; Jacobsen A; Sinha R; Larsson E; Cerami E; Sander C; Schultz N
Sci Signal; 2013 Apr; 6(269):pl1. PubMed ID: 23550210
[TBL] [Abstract][Full Text] [Related]
55. Phylogenetic analysis of cubilin (CUBN) gene.
Shaik AP; Alsaeed AH; Kiranmayee S; Bammidi V; Sultana A
Bioinformation; 2013; 9(1):29-36. PubMed ID: 23390341
[TBL] [Abstract][Full Text] [Related]
56. Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis.
Wu WK; Wang XJ; Cheng AS; Luo MX; Ng SS; To KF; Chan FK; Cho CH; Sung JJ; Yu J
Crit Rev Oncol Hematol; 2013 Jun; 86(3):251-77. PubMed ID: 23287077
[TBL] [Abstract][Full Text] [Related]
57. High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes.
Choy E; Hornicek F; MacConaill L; Harmon D; Tariq Z; Garraway L; Duan Z
Cancer; 2012 Jun; 118(11):2905-14. PubMed ID: 22006429
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.
Liu X; Zhang Z; Sun L; Chai N; Tang S; Jin J; Hu H; Nie Y; Wang X; Wu K; Jin H; Fan D
Carcinogenesis; 2011 Dec; 32(12):1798-805. PubMed ID: 21934092
[TBL] [Abstract][Full Text] [Related]
59. PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.
Kwon IK; Wang R; Thangaraju M; Shuang H; Liu K; Dashwood R; Dulin N; Ganapathy V; Browning DD
Oncogene; 2010 Jun; 29(23):3423-34. PubMed ID: 20348951
[TBL] [Abstract][Full Text] [Related]
60. Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer.
Bardelli A; Siena S
J Clin Oncol; 2010 Mar; 28(7):1254-61. PubMed ID: 20100961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
